Description: Creso Pharma Limited is an Australia-based company engaged in developing cannabis and hemp-derived therapeutic-grade Nutraceuticals and Medical Cannabis products with a range of applications in both human and animal health. The Company's principal activity is to develop, register and commercialize pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments. The Company's segments include Hemp-Industries s.r.o. (Hemp-Industries), which includes hemp-growing operations, outsourced cannabidiol (CBD) extraction and CBD product sales activities; Creso Pharma Switzerland GmbH (Switzerland), which includes the development and commercialization of its therapeutic products, and Creso Pharma Limited (Creso), which includes the Company's corporate administration. The Company primarily offers human health and animal health products, and hemp-derived extracts, oils and proteins.
Home Page: www.cresopharma.com
CPH Technical Analysis
145 Stirling Highway
Nedlands,
WA
6009
Australia
Phone:
61 8 9389 3180
Officers
| Name | Title |
|---|---|
| Mr. Boaz Wachtel M.A., M.D., MBA | Co-Founder & Non-Exec. Chairman |
| Mr. Christopher Grundy | Chief Financial Officer |
| Mr. William Lay B.Com. | Group CEO, MD & Director |
| Dr. Gian Trepp | Commercial & Marketing Director |
| Ms. Micheline MacKay B.Sc., M.Sc., P.M.P. | MD & Exec. Director |
| Ms. Jodi Scott | Exec. Director & Pres of US Operations |
| Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG | Joint Company Sec. |
| Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom | Joint Company Sec. |
| Dr. Simon H. W. Buckingham | Consultant |
| Hon. Brian Walker | Strategic Consultant & Chair of Scientific Advisory Committee |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3309 |
| Price-to-Sales TTM: | 4.8771 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |